Cardiovascular Genetic Testing Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Cardiovascular Genetic Testing Market Report 2026

Name: Cardiovascular Genetic Testing Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Testing Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Testing Types), By Disease (Inherited Cardiomyopathies, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Arrhythmia, Aortopathies, Other Diseases), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Chromosome Analysis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications), By End User (Hospitals And Clinics, Diagnostic Laboratories, Research Institutions, Genetic Counseling Centers, Pharmaceutical Companies, Direct-To-Consumer Testing) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Cardiovascular Genetic Testing Market Overview

• Cardiovascular Genetic Testing market size has reached to $3.93 billion in 2025

• Expected to grow to $6.62 billion in 2030 at a compound annual growth rate (CAGR) of 11%

• Growth Driver: Rising Prevalence Of Cardiovascular Diseases Fueling The Growth Of The Market Due To Increasing Demand For Early Risk Detection And Personalized Treatment

• Market Trend: Innovative Clinician-Ordered Genetic Tests Enhancing Personalized Cardiovascular Risk Assessment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiovascular Genetic Testing Market?

Cardiovascular genetic testing refers to the analysis of an individual’s DNA to identify inherited genetic variations that increase the risk of developing heart and blood vessel disorders, enabling early diagnosis, personalized treatment planning, and targeted preventive strategies. It helps clinicians predict disease susceptibility, guide medication selection, assess familial risk, and support proactive management of cardiovascular conditions through precision medicine approaches.

The main testing types of cardiovascular genetic testing include predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and other testing types. Predictive testing refers to genetic tests that assess an individual’s risk of developing cardiovascular conditions before symptoms appear. These tests are used for diseases such as inherited cardiomyopathies, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmia, aortopathies, and other diseases. The technologies involved include cytogenetic testing, biochemical testing, and molecular testing. The applications include chromosome analysis, genetic disease diagnosis, cardiovascular disease diagnosis, and other applications, and the end users are hospitals and clinics, diagnostic laboratories, research institutions, genetic counseling centers, pharmaceutical companies, and direct-to-consumer testing.

Cardiovascular Genetic Testing Market Report bar graph

What Is The Cardiovascular Genetic Testing Market Size and Share 2026?

The cardiovascular genetic testing market size has grown rapidly in recent years. It will grow from $3.93 billion in 2025 to $4.35 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing awareness of inherited cardiovascular disorders, expansion of molecular diagnostic capabilities, declining costs of genetic sequencing, growing use of genetic counseling services, increased research in cardiovascular genomics.

What Is The Cardiovascular Genetic Testing Market Growth Forecast?

The cardiovascular genetic testing market size is expected to see rapid growth in the next few years. It will grow to $6.62 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing demand for precision medicine approaches, rising adoption of population-based genetic screening, expansion of AI-driven variant interpretation, growing integration of genomics in clinical decision making, increasing focus on preventive cardiovascular healthcare. Major trends in the forecast period include increasing adoption of predictive genetic risk assessment, rising use of multigene panel testing, growing integration of bioinformatics and AI analytics, expansion of pharmacogenomic testing applications, enhanced focus on personalized cardiovascular care.

Book your 30 minutes free consultation with our research experts

Global Cardiovascular Genetic Testing Market Segmentation

1) By Testing Type: Predictive Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing; Other Testing Types

2) By Disease: Inherited Cardiomyopathies; Hypertrophic Cardiomyopathy (HCM); Dilated Cardiomyopathy (DCM); Arrhythmia; Aortopathies; Other Diseases

3) By Technology: Cytogenetic Testing; Biochemical Testing; Molecular Testing

4) By Application: Chromosome Analysis; Genetic Disease Diagnosis; Cardiovascular Disease Diagnosis; Other Applications

5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutions; Genetic Counseling Centers; Pharmaceutical Companies; Direct-To-Consumer Testing

Subsegments:

1) By Predictive Testing: Presymptomatic Risk Assessment; Familial Variant Screening; Polygenic Risk Evaluation; Late Onset Disease Prediction; Susceptibility Gene Testing

2) By Carrier Testing: Autosomal Recessive Carrier Screening; Linked Carrier Screening; Expanded Carrier Screening Panels; Single Gene Carrier Screening; Family History Based Carrier Testing

3) By Prenatal And Newborn Testing: Non Invasive Prenatal Genetic Testing; Invasive Prenatal Diagnostic Testing; Newborn Metabolic Screening; Congenital Heart Disease Genetic Screening; Neonatal Gene Panel Testing

4) By Diagnostic Testing: Single Gene Diagnostic Testing; Multigene Panel Diagnostic Testing; Whole Exome Diagnostic Testing; Whole Genome Diagnostic Testing; Variant Confirmation Testing

5) By Pharmacogenomic Testing: Drug Response Gene Testing; Adverse Drug Reaction Risk Testing; Dose Optimization Genetic Testing; Anticoagulant Response Testing; Cardiovascular Drug Metabolism Testing

6) By Other Testing Types: Cascade Family Testing; Population Based Genetic Screening; Research Use Genetic Testing; Confirmatory Follow Up Testing; Clinical Trial Genetic Testing

What Is The Driver Of The Cardiovascular Genetic Testing Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the cardiovascular genetic testing market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. The prevalence of cardiovascular diseases is rising primarily due to increasing sedentary lifestyles associated with urbanization, which contribute to obesity, hypertension, and metabolic disorders. The increasing incidence of cardiovascular diseases drives demand for cardiovascular genetic testing, as detecting genetic risks early enables personalized prevention and treatment strategies to lower the likelihood of serious heart complications. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disease is driving the growth of the cardiovascular genetic testing industry.

Key Players In The Global Cardiovascular Genetic Testing Market

Major companies operating in the cardiovascular genetic testing market are Labcorp Holdings Inc., Quest Diagnostics Inc., ICON plc, Illumina Inc., Apollo Hospitals, OPKO Health Inc., Revvity Inc., ARUP Laboratories Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., MedGenome Inc., Genome Medical, PreventionGenetics, Eurofins Genomics LLC, Blueprint Genetics Inc., MapmyGenome, GENinCode, Allelica Srl, Rocket Pharma Inc., and Health in Code SL.

Global Cardiovascular Genetic Testing Market Trends and Insights

Major companies operating in the cardiovascular genetic testing market are focusing on developing innovative solutions, such as clinician-ordered tests, to help ensure the test is medically necessary and tailored to the patient’s specific health condition, reducing unnecessary testing and costs. A clinician-ordered test is a medical examination or diagnostic procedure requested by a healthcare professional to evaluate, monitor, or guide the management of a patient’s health condition. For instance, in September 2025, Mass General Brigham, a US-based not-for-profit integrated academic healthcare system, in collaboration with Broad Clinical Labs, a US-based genomic data generation laboratory, and Mass General Brigham Laboratory for Molecular Medicine, a US-based molecular diagnostic laboratory, launched a genetic test that evaluates inherited risk for eight cardiovascular conditions. The clinician-ordered test is offered on a self-pay basis and evaluates genetic predisposition to eight conditions, including atrial fibrillation, coronary artery disease, type 2 diabetes, elevated lipoprotein(a), hypercholesterolemia, hypertension, thoracic aortic aneurysm, and venous thromboembolism. Its development utilized genotype and clinical data from 236,393 participants in the NIH’s All of Us Research Program. Publicly available polygenic risk scores for each condition were integrated using PRSmix, an elastic-net modeling approach that combines multiple component scores into a single, comprehensive risk score per disease. High-resolution genetic data is captured through a clinical blended genome-exome assay at Broad Clinical Labs, while the CLIA-certified Mass General Brigham Laboratory for Molecular Medicine interprets the results and generates patient-friendly reports.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cardiovascular Genetic Testing Market?

In February 2025, Tempus AI Inc., a US-based precision medicine company, acquired Ambry Genetics for an undisclosed amount. The acquisition strengthens the strategy of leveraging diagnostics and data to drive innovation. It enhances the ability to deliver advanced solutions to clinicians, patients, and life sciences companies. Ambry Genetics Corporation is a US-based company specializing in cardiovascular genetic testing.

Regional Insights

North America was the largest region in the cardiovascular genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiovascular Genetic Testing Market?

The cardiovascular genetic testing market includes revenues earned by entities through genetic testing services, genetic screening services, molecular diagnostic services, genomic sequencing services, variant interpretation services, bioinformatics analysis services, genetic counseling services, and personalized risk assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiovascular Genetic Testing Market Report 2026?

The cardiovascular genetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular genetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cardiovascular Genetic Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.35 billion
Revenue Forecast In 2035	$6.62 billion
Growth Rate	CAGR of 10.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Testing Type, Disease, Technology, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Labcorp Holdings Inc., Quest Diagnostics Inc., ICON plc, Illumina Inc., Apollo Hospitals, OPKO Health Inc., Revvity Inc., ARUP Laboratories Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., MedGenome Inc., Genome Medical, PreventionGenetics, Eurofins Genomics LLC, Blueprint Genetics Inc., MapmyGenome, GENinCode, Allelica Srl, Rocket Pharma Inc., and Health in Code SL.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cardiovascular Genetic Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cardiovascular Genetic Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cardiovascular Genetic Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cardiovascular Genetic Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Adoption Of Predictive Genetic Risk Assessment

4.2.2 Rising Use Of Multigene Panel Testing

4.2.3 Growing Integration Of Bioinformatics And AI Analytics

4.2.4 Expansion Of Pharmacogenomic Testing Applications

4.2.5 Enhanced Focus On Personalized Cardiovascular Care

5. Cardiovascular Genetic Testing Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Laboratories

5.3 Research Institutions

5.4 Genetic Counseling Centers

5.5 Pharmaceutical Companies

6. Cardiovascular Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiovascular Genetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cardiovascular Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cardiovascular Genetic Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cardiovascular Genetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cardiovascular Genetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiovascular Genetic Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiovascular Genetic Testing Market Segmentation

9.1. Global Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Testing Types

9.2. Global Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inherited Cardiomyopathies, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Arrhythmia, Aortopathies, Other Diseases

9.3. Global Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cytogenetic Testing, Biochemical Testing, Molecular Testing

9.4. Global Cardiovascular Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chromosome Analysis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications

9.5. Global Cardiovascular Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Laboratories, Research Institutions, Genetic Counseling Centers, Pharmaceutical Companies, Direct-To-Consumer Testing

9.6. Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Presymptomatic Risk Assessment, Familial Variant Screening, Polygenic Risk Evaluation, Late Onset Disease Prediction, Susceptibility Gene Testing

9.7. Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autosomal Recessive Carrier Screening, Linked Carrier Screening, Expanded Carrier Screening Panels, Single Gene Carrier Screening, Family History Based Carrier Testing

9.8. Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Prenatal And Newborn Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non Invasive Prenatal Genetic Testing, Invasive Prenatal Diagnostic Testing, Newborn Metabolic Screening, Congenital Heart Disease Genetic Screening, Neonatal Gene Panel Testing

9.9. Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Gene Diagnostic Testing, Multigene Panel Diagnostic Testing, Whole Exome Diagnostic Testing, Whole Genome Diagnostic Testing, Variant Confirmation Testing

9.10. Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Response Gene Testing, Adverse Drug Reaction Risk Testing, Dose Optimization Genetic Testing, Anticoagulant Response Testing, Cardiovascular Drug Metabolism Testing

9.11. Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Other Testing Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cascade Family Testing, Population Based Genetic Screening, Research Use Genetic Testing, Confirmatory Follow Up Testing, Clinical Trial Genetic Testing

10. Cardiovascular Genetic Testing Market Regional And Country Analysis

10.1. Global Cardiovascular Genetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cardiovascular Genetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiovascular Genetic Testing Market

11.1. Asia-Pacific Cardiovascular Genetic Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiovascular Genetic Testing Market

12.1. China Cardiovascular Genetic Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiovascular Genetic Testing Market

13.1. India Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiovascular Genetic Testing Market

14.1. Japan Cardiovascular Genetic Testing Market Overview

14.2. Japan Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiovascular Genetic Testing Market

15.1. Australia Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiovascular Genetic Testing Market

16.1. Indonesia Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiovascular Genetic Testing Market

17.1. South Korea Cardiovascular Genetic Testing Market Overview

17.2. South Korea Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiovascular Genetic Testing Market

18.1. Taiwan Cardiovascular Genetic Testing Market Overview

18.2. Taiwan Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiovascular Genetic Testing Market

19.1. South East Asia Cardiovascular Genetic Testing Market Overview

19.2. South East Asia Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiovascular Genetic Testing Market

20.1. Western Europe Cardiovascular Genetic Testing Market Overview

20.2. Western Europe Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiovascular Genetic Testing Market

21.1. UK Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiovascular Genetic Testing Market

22.1. Germany Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiovascular Genetic Testing Market

23.1. France Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiovascular Genetic Testing Market

24.1. Italy Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiovascular Genetic Testing Market

25.1. Spain Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiovascular Genetic Testing Market

26.1. Eastern Europe Cardiovascular Genetic Testing Market Overview

26.2. Eastern Europe Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiovascular Genetic Testing Market

27.1. Russia Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiovascular Genetic Testing Market

28.1. North America Cardiovascular Genetic Testing Market Overview

28.2. North America Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiovascular Genetic Testing Market

29.1. USA Cardiovascular Genetic Testing Market Overview

29.2. USA Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiovascular Genetic Testing Market

30.1. Canada Cardiovascular Genetic Testing Market Overview

30.2. Canada Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiovascular Genetic Testing Market

31.1. South America Cardiovascular Genetic Testing Market Overview

31.2. South America Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiovascular Genetic Testing Market

32.1. Brazil Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiovascular Genetic Testing Market

33.1. Middle East Cardiovascular Genetic Testing Market Overview

33.2. Middle East Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiovascular Genetic Testing Market

34.1. Africa Cardiovascular Genetic Testing Market Overview

34.2. Africa Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Segmentation By Disease, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiovascular Genetic Testing Market Regulatory and Investment Landscape

36. Cardiovascular Genetic Testing Market Competitive Landscape And Company Profiles

36.1. Cardiovascular Genetic Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cardiovascular Genetic Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cardiovascular Genetic Testing Market Company Profiles

36.3.1. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. ICON plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Apollo Hospitals Overview, Products and Services, Strategy and Financial Analysis

37. Cardiovascular Genetic Testing Market Other Major And Innovative Companies

OPKO Health Inc., Revvity Inc., ARUP Laboratories Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., MedGenome Inc., Genome Medical, PreventionGenetics, Eurofins Genomics LLC, Blueprint Genetics Inc., MapmyGenome, GENinCode, Allelica Srl, Rocket Pharma Inc., Health in Code SL

38. Global Cardiovascular Genetic Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Cardiovascular Genetic Testing Market

41. Cardiovascular Genetic Testing Market High Potential Countries, Segments and Strategies

41.1 Cardiovascular Genetic Testing Market In 2030 - Countries Offering Most New Opportunities

41.2 Cardiovascular Genetic Testing Market In 2030 - Segments Offering Most New Opportunities

41.3 Cardiovascular Genetic Testing Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cardiovascular Genetic Testing Market, Overview Of Key Products - Product Examples

Table 2: Global Cardiovascular Genetic Testing Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cardiovascular Genetic Testing Market, Supply Chain Analysis

Table 4: Global Cardiovascular Genetic Testing Market, Major Raw Material Providers

Table 5: Global Cardiovascular Genetic Testing Market, Major Resource Providers

Table 6: Global Cardiovascular Genetic Testing Market, Major Manufacturers (Suppliers)

Table 7: Global Cardiovascular Genetic Testing Market, Major Distributors And Channel Partners

Table 8: Global Cardiovascular Genetic Testing Market, Key Technologies & Future Trends

Table 9: Global Cardiovascular Genetic Testing Market, Major Trends

Table 10: Global Cardiovascular Genetic Testing Market, Major End Users

Table 11: Global Cardiovascular Genetic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cardiovascular Genetic Testing Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cardiovascular Genetic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cardiovascular Genetic Testing Market - TAM, US$ Billion, 2025

Table 15: Global Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cardiovascular Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cardiovascular Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Prenatal And Newborn Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Other Testing Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Cardiovascular Genetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Cardiovascular Genetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Global Cardiovascular Genetic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 101: Global Cardiovascular Genetic Testing Market - Company Scoring Matrix

Table 102: Upcoming Startups

Table 103: Labcorp Holdings Inc. Financial Performance

Table 104: Quest Diagnostics Inc. Financial Performance

Table 105: ICON plc Financial Performance

Table 106: Illumina Inc. Financial Performance

Table 107: Apollo Hospitals Financial Performance

Table 108: Global Cardiovascular Genetic Testing Market, Competitive Benchmarking (In USD Billions)

Table 109: Global Cardiovascular Genetic Testing Market, Competitive Dashboard

Table 110: Global Cardiovascular Genetic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 111: Global, Cardiovascular Genetic Testing Market Size Gain ($ Billion), Segmentation By Testing Type, 2025 – 2030

Table 112: Global, Cardiovascular Genetic Testing Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Table 113: Global, Cardiovascular Genetic Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

Figure 1: Global Cardiovascular Genetic Testing Market, Overview Of Key Products - Product Examples

Figure 2: Global Cardiovascular Genetic Testing Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cardiovascular Genetic Testing Market, Supply Chain Analysis

Figure 4: Global Cardiovascular Genetic Testing Market, Major Raw Material Providers

Figure 5: Global Cardiovascular Genetic Testing Market, Major Resource Providers

Figure 6: Global Cardiovascular Genetic Testing Market, Major Manufacturers (Suppliers)

Figure 7: Global Cardiovascular Genetic Testing Market, Major Distributors And Channel Partners

Figure 8: Global Cardiovascular Genetic Testing Market, Key Technologies & Future Trends

Figure 9: Global Cardiovascular Genetic Testing Market, Major Trends

Figure 10: Global Cardiovascular Genetic Testing Market, Major End Users

Figure 11: Global Cardiovascular Genetic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cardiovascular Genetic Testing Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cardiovascular Genetic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cardiovascular Genetic Testing Market - TAM, US$ Billion, 2025

Figure 15: Global Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cardiovascular Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cardiovascular Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Prenatal And Newborn Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Cardiovascular Genetic Testing Market, Sub-Segmentation Of Other Testing Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Cardiovascular Genetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Cardiovascular Genetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Cardiovascular Genetic Testing Market, Segmentation By Testing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Cardiovascular Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Cardiovascular Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Global Cardiovascular Genetic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 101: Global Cardiovascular Genetic Testing Market - Company Scoring Matrix

Figure 102: Upcoming Startups

Figure 103: Labcorp Holdings Inc. Financial Performance

Figure 104: Quest Diagnostics Inc. Financial Performance

Figure 105: ICON plc Financial Performance

Figure 106: Illumina Inc. Financial Performance

Figure 107: Apollo Hospitals Financial Performance

Figure 108: Global Cardiovascular Genetic Testing Market, Competitive Benchmarking (In USD Billions)

Figure 109: Global Cardiovascular Genetic Testing Market, Competitive Dashboard

Figure 110: Global Cardiovascular Genetic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 111: Global, Cardiovascular Genetic Testing Market Size Gain ($ Billion), Segmentation By Testing Type, 2025 – 2030

Figure 112: Global, Cardiovascular Genetic Testing Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Figure 113: Global, Cardiovascular Genetic Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Genetic Testing Market Report 2026 - Global Outlook – By Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types), By Techn...

Direct-To-Consumer (DTC) Genetic Testing Market Report 2026 - Global Outlook – By Type (Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types), By Sample (Saliva, Urine...

Genetic Testing Services Market Report 2026 - Global Outlook – By Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Other Types), By Disease (Cancer Disease, Metabolic Disease, Cardiovascula...

Cardiac Biomarkers Testing Market Report 2026 - Global Outlook – By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomark...

Prenatal And Newborn Genetic Testing Market Report 2026 - Global Outlook – By Product Type (Consumables, Instruments), By Screening (Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum S...

Cardiovascular Health Supplements Market Report 2026 - Global Outlook – By Type (Natural Supplements, Synthetic Supplements), By Ingredient (Vitamins And Minerals, Herbs And Botanicals, Omega Fatty Acids, Coenzyme Q10 (C...

Cardiac Biomarkers Market Report 2026 - Global Outlook – By Biomarker Type (Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA)), By Location Of Testin...

Frequently Asked Questions

How big is the Cardiovascular Genetic Testing Market?

The Cardiovascular Genetic Testing market was valued at $3.93 billion in 2025, increased to $4.35 billion in 2026, and is projected to reach $6.62 billion by 2030.

What is the Cardiovascular Genetic Testing market growth?

The global Cardiovascular Genetic Testing market is expected to grow at a CAGR of 11.0% from 2026 to 2035 to reach $6.62 billion by 2035.

Who are the key players in Cardiovascular Genetic Testing market?

Some Key Players in the Cardiovascular Genetic Testing market Include, Labcorp Holdings Inc., Quest Diagnostics Inc., ICON plc, Illumina Inc., Apollo Hospitals, OPKO Health Inc., Revvity Inc., ARUP Laboratories Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., MedGenome Inc., Genome Medical, PreventionGenetics, Eurofins Genomics LLC, Blueprint Genetics Inc., MapmyGenome, GENinCode, Allelica Srl, Rocket Pharma Inc., and Health in Code SL. .

What is the anticipated growth trend for the Cardiovascular Genetic Testing market?

Major trend in this market includes: Innovative Clinician-Ordered Genetic Tests Enhancing Personalized Cardiovascular Risk Assessment. For further insights on this market. request a sample here

Which region has the most growth potential in the Cardiovascular Genetic Testing market?

North America was the largest region in the cardiovascular genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.